Müller, Daniel J.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments

Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 1,181

The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies

Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022) · International Journal of Molecular Sciences

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 202

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

Lopez, J. P., Fiori, L. M., Cruceanu, C., Lin, R., Labonte, B., Cates, H. M., Heller, E. A., Vialou, V., Ku, S. M., Gerald, C., et al. (2017) · Nature Communications

Treatment of Major DepressionMicroRNA in disease regulation

Cited by 201

Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature

Fonseka, T. M., Richter, M. A., & Müller, D. J. (2014) · Current Psychiatry Reports

Schizophrenia research and treatmentObsessive-Compulsive Spectrum Disorders

Cited by 93

The effects of video games on cognition and brain structure: potential implications for neuropsychiatric disorders

Shams, T. A., Foussias, G., Zawadzki, J. A., Marshe, V. S., Siddiqui, I., Müller, D. J., & Wong, A. H. C. (2015) · Current Psychiatry Reports

Cognitive Abilities and TestingEducational Games and Gamification

Cited by 68

The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

MacQueen, G. M., Hassel, S., Arnott, S. R., Addington, J., Bowie, C. R., Bray, S. L., Davis, A. D., Downar, J., Foster, J. A., Frey, B. N., et al. (2019) · Journal of Psychiatry and Neuroscience

Treatment of Major DepressionFunctional Brain Connectivity Studies

Cited by 57

Linking unfounded beliefs to genetic dopamine availability

Schmack, K., Rössler, H., Sekutowicz, M., Brandl, E. J., Müller, D. J., Petrovic, P., & Sterzer, P. (2015) · Frontiers in Human Neuroscience

Paranormal Experiences and BeliefsNeurotransmitter Receptor Influence on Behavior

Cited by 24

Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report

Uher, R., Frey, B. N., Quilty, L. C., Rotzinger, S., Blier, P., Foster, J. A., Müller, D. J., Ravindran, A. V., Soares, C. N., Turecki, G., et al. (2020) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 19

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

Slyepchenko, A., Uher, R., Ho, K., Hassel, S., Matthews, C., Lukus, P. K., Daros, A. R., Minarik, A., Placenza, F., Li, Q. S., et al. (2023) · Scientific Reports

Sleep and related disordersContext-Aware Activity Recognition Systems

Cited by 17

One-year actigraphy study of sleep and rest-activity rhythms as markers of relapse in depression

Tonon, A. C., Nexha, A., Cunningham, J. E. A., d’Eon, J., Chakrabarty, T., Farzan, F., Foster, J. A., Harkness, K. L., Hassel, S., Ho, K., et al. (2026) · JAMA Psychiatry

Sleep and related disordersCircadian rhythm and melatonin

Cited by 9

Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression

Islam, F., Gorbovskaya, I., & Müller, D. J. (2021) · Advances in Experimental Medicine and Biology

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 6